Curated summary · agent-written · kb/genes/curated/hgnc_4335.md
All 12 claims checked against the KB draft

GLUD1 across dismech

GLUD1 (glutamate dehydrogenase 1) is named by 2 disorder entries, including Congenital Isolated Hyperinsulinism; and Hyperinsulinemic Hypoglycemia.

Normal function

ai-gene-review gives GLUD1's core molecular functions as ADP binding; and L-glutamate dehydrogenase [NAD(P)+] activity, in the mitochondrial matrix, acting in L-glutamate catabolic process; and tricarboxylic acid metabolic process.

Causative records

Both entries record the variant origin as germline, and ClinGen rates the gene definitive for hyperinsulinism-hyperammonemia syndrome, a subtype of each entry. The gene sits on Glutamate Dehydrogenase Dysregulation (Amino-Acid-Driven HI) and Glutamate Dehydrogenase Amino-Acid Amplifier Activation. The disease is gain of function: the Congenital Isolated Hyperinsulinism node records glutamate dehydrogenase activity as increased, the same activity that is the gene's normal core function.

Where the layers disagree

The KB and ai-gene-review share 0 GO process terms: the KB nodes are annotated with insulin-secretion processes, the review with glutamate catabolism.

Underlined values are claims re-computed from the knowledge base each time this page is built. The tables below are the source of truth.

Normal function · from ai-gene-review (P00367, commit 79fe13b38970) · AI-generated, not KB evidence

ai-gene-review has this gene at status INITIALIZED; the description is shown only once the review is complete. Read the draft upstream.

In the knowledge base · computed from kb/ at build time

Disorders

Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.

DisorderRelationshipWhere the gene appears
Congenital Isolated Hyperinsulinism causative germline
CLINGEN: definitive
mechanism: Glutamate Dehydrogenase Dysregulation (Amino-Acid-Driven HI)
subtype: HI/HA Syndrome
scoped to subtype: HI/HA Syndrome
Hyperinsulinemic Hypoglycemia causative germline
CLINGEN: definitive
mechanism: Glutamate Dehydrogenase Amino-Acid Amplifier Activation
subtype: HI/HA Syndrome
scoped to subtype: HI/HA Syndrome
ClinGen gene–disease validity · snapshot 2026-10-03 · matched to entries by MONDO

An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.

ClinGen diseaseMOIClassificationdismech entry
hyperinsulinism-hyperammonemia syndrome MONDO:0011717 AD Definitive
2020-11-13

Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.